Trial
NCT02462759
A Study to Assess the Safety and Tolerability of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA).
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Biogen
Collaborators
—
Condition
Spinal Muscular Atrophy
Intervention
Nusinersen
Why stopped
The study was terminated early to roll over participants to open label extension study NCT02594124.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-02-17